LENZILUMAB
Humanigen, Inc.
Mark For: LENZILUMAB™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90169030 |
| Mark Literal Elements | LENZILUMAB |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 130 2021-02-25 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Jacqueline Zion |
| Attorney Docket Number | T-598919-US |
Timeline
| 2020-09-09 | Application Filed |
| 2020-09-12 | Location: NEW APPLICATION PROCESSING |
| 2020-09-12 | Status: Live/Pending |
| 2020-09-12 | Transaction Date |
| 2021-02-25 | Location: TMO LAW OFFICE 130 |
| 2021-02-25 | Status: New application assigned to an examining attorney for examination. |
Trademark Parties (Applicants & Owners)
| Party: |  HUMANIGEN, INC. |
| Address | 533 Airport Boulevard, Suite 400 Burlingame, CALIFORNIA UNITED STATES 94010 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | MULTI | 2020-09-09 |
 Drawing | JPEG | 2020-09-09 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ASSIGNED TO EXAMINER | 2021-02-25 | 93051 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-15 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-09-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 